Evidence map›Paper›PMID 22908044›Full record

ArticleG3 (Bethesda, Md.)2012

Forward genetic analysis to identify determinants of dopamine signaling in Caenorhabditis elegans using swimming-induced paralysis.

J Andrew Hardaway, Shannon L Hardie, Sarah M Whitaker, Sarah R Baas, Bing Zhang, Daniel P Bermingham, Ariana J Lichtenstein, Randy D Blakely

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. A Forward Genetic Screen inbioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. The dopaminergic system ofRoyal Society open science · 2025
    Review
  4. Review
  5. GlialProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Optical Imaging Demonstrates Tissue-Specific Metabolic Perturbations in Mblac1 Knockout Mice.IEEE journal of translational engineering in health and medicine · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

J Andrew HardawayDepartment of Pharmacology, and Silvio O. Conte Center for Neuroscience Research, Vanderbilt University School of Medicine, Nashville, TN 37232-8548, USA.
Shannon L Hardie
Sarah M Whitaker
Sarah R Baas
Bing Zhang
Daniel P Bermingham
Ariana J Lichtenstein
Randy D Blakely
Center for Neurosciences · US

Funding

Training in Fundamental NeuroscienceT32MH064913 · NIMH · VANDERBILT UNIVERSITY · PI IHRIE, REBECCA A, WINDER, DANNY G. · 2001 to 2022
$7.6M
Alliance for Research Training in NeuroscienceT32MH065782 · NIMH · VANDERBILT UNIVERSITY · PI BUSH, ELAINE SANDERS · 2002 to 2006
$2.6M
PRESYNAPTIC REGULATION OF C.ELEGANS DOPAMINE TRANSPORTERR01MH095044 · NIMH · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2012 to 2016
$2.2M
Forward Genetics and the Presynaptic Dopamine TransporterR21DA027739 · NIDA · VANDERBILT UNIVERSITY · PI BLAKELY, RANDY D. · 2009 to 2010
$309k
Presynaptic Mechanisms Regulating the Dopamine TransporterF31MH093102 · NIMH · VANDERBILT UNIVERSITY · PI HARDAWAY, JAMES ANDREW · 2010 to 2013
$75k
CLOZAPINE VS HALOPERIDOL: COMPARISON OF MODE OF ACTIONF32MH009504 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI HAND, TIMOTHY H · 1986 to 1987
–
NIDA NIH HHS DA027739NIDA NIH HHS R21 DA027739NIMH NIH HHS F31 MH093102NIMH NIH HHS F31MH093102-01NIMH NIH HHS MH065782NIMH NIH HHS MH09504NIMH NIH HHS R01 MH095044NIMH NIH HHS T32 MH064913NIMH NIH HHS T32 MH065782
6 · The paper itself

Abstract

Disrupted dopamine (DA) signaling is believed to contribute to the core features of multiple neuropsychiatric and neurodegenerative disorders. Essential features of DA neurotransmission are conserved in the nematode Caenorhabditis elegans, providing us with an opportunity to implement forward genetic approaches that may reveal novel, in vivo regulators of DA signaling. Previously, we identified a robust phenotype, termed Swimming-induced paralysis (Swip), that emerges in animals deficient in the plasma membrane DA transporter. Here, we report the use and quantitative analysis of Swip in the identification of mutant genes that control DA signaling. Two lines captured in our screen (vt21 and vt22) bear novel dat-1 alleles that disrupt expression and surface trafficking of transporter proteins in vitro and in vivo. Two additional lines, vt25 and vt29, lack transporter mutations but exhibit genetic, biochemical, and behavioral phenotypes consistent with distinct perturbations of DA signaling. Our studies validate the utility of the Swip screen, demonstrate the functional relevance of DA transporter structural elements, and reveal novel genomic loci that encode regulators of DA signaling.

Indexed as

Adrenergic Uptake InhibitorsAnimalsAnimals, Genetically ModifiedCaenorhabditis elegansCaenorhabditis elegans ProteinsDopamineDopamine Plasma Membrane Transport ProteinsMotor ActivityMutationPhenotypePolymorphism, Single NucleotideReserpineSignal TransductionSwimmingAdrenergic Uptake InhibitorsCaenorhabditis elegans ProteinsDAT-1 protein, C elegansDopamineDopamine Plasma Membrane Transport ProteinsReserpineCaenorhabditis elegansdopamineforward geneticspresynapticreceptortransporter

Identifiers

PMID22908044
PMCPMC3411251
OpenAlexW2052414114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.